Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Quanterix Corporation engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; SR-X and SP-X instruments. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $86.4M | $110.6M | $105.5M | $122.4M | $137.4M | $138.9M |
| Gross profit | $48.2M | $64.8M | $45.4M | $74.2M | $83.1M | $65.0M |
| Operating income | -$31.6M | -$56.5M | -$104.3M | -$46.0M | -$52.6M | -$125.5M |
| Net income | -$31.5M | -$55.5M | -$99.6M | -$28.4M | -$38.5M | -$107.2M |
| Diluted EPS | -$1.07 | -$1.54 | -$2.69 | -$0.75 | -$1.00 | -$2.51 |
| Operating cash flow | -$23.4M | -$47.6M | -$48.6M | -$18.8M | -$35.2M | -$77.2M |
| Free cash flow | -$27.3M | -$61.3M | -$60.2M | -$22.7M | -$38.5M | -$79.8M |
| Gross margin | 55.8% | 58.6% | 43.0% | 60.7% | 60.5% | 46.8% |
| Operating margin | -36.6% | -51.1% | -98.8% | -37.6% | -38.3% | -90.4% |
| Net margin | -36.5% | -50.2% | -94.4% | -23.2% | -28.0% | -77.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34.4M | $35.8M | $35.2M | $30.3M | $24.5M | $40.2M | $43.9M | $36.4M |
| Gross profit | $22.2M | $20.2M | $22.2M | $14.8M | $11.3M | $17.2M | $21.6M | $15.6M |
| Operating income | -$10.9M | -$11.7M | -$14.8M | -$26.4M | -$37.1M | -$37.3M | -$24.8M | -$41.4M |
| Net income | -$7.4M | -$8.4M | -$11.6M | -$20.5M | -$30.0M | -$33.5M | -$23.1M | -$17.5M |
| Diluted EPS | -$0.19 | -$0.22 | -$0.30 | -$0.53 | -$0.77 | -$0.73 | -$0.48 | -$0.37 |
| Operating cash flow | -$5.0M | -$5.7M | -$4.3M | -$13.9M | -$5.7M | -$41.2M | -$16.4M | -$18.1M |
| Free cash flow | -$6.5M | -$6.6M | -$4.7M | -$15.1M | -$6.4M | -$41.9M | -$16.5M | -$18.2M |
| Gross margin | 64.7% | 56.3% | 63.0% | 48.9% | 46.2% | 42.8% | 49.3% | 42.7% |
| Operating margin | -31.8% | -32.8% | -42.0% | -86.9% | -151.6% | -92.8% | -56.4% | -113.6% |
| Net margin | -21.5% | -23.3% | -33.1% | -67.6% | -122.6% | -83.3% | -52.7% | -48.2% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | Miller Michael Francis· Chief Technology Officer | Tax withholding | 249 | $4.24 | $1,055.76 | filing |
| 2026-07-15 | Miller Michael Francis· Chief Technology Officer | Tax withholding | 111 | $4.24 | $470.64 | filing |
| 2026-07-15 | Miller Michael Francis· Chief Technology Officer | Tax withholding | 41 | $4.24 | $173.84 | filing |
| 2026-07-15 | Miller Michael Francis· Chief Technology Officer | Tax withholding | 41 | $4.24 | $173.84 | filing |
| 2026-07-15 | Miller Michael Francis· Chief Technology Officer | Tax withholding | 25 | $4.24 | $106.00 | filing |
| 2026-07-15 | Miller Michael Francis· Chief Technology Officer | Option exercise | 81 | — | — | filing |
| 2026-07-15 | Miller Michael Francis· Chief Technology Officer | Option exercise | 136 | — | — | filing |
| 2026-07-15 | Miller Michael Francis· Chief Technology Officer | Option exercise | 135 | — | — | filing |
| 2026-07-15 | Miller Michael Francis· Chief Technology Officer | Option exercise | 372 | — | — | filing |
| 2026-07-15 | Miller Michael Francis· Chief Technology Officer | Option exercise | 834 | — | — | filing |
| 2026-07-08 | Mendel Scott | Option exercise | 8,073 | — | — | filing |
| 2026-07-08 | LAI GOLDMAN MYLA | Option exercise | 8,073 | — | — | filing |
| 2026-07-01 | DONNELLY WILLIAM P | Award | 5,472 | $4.34 | $23,748.48 | filing |
| 2026-07-01 | Mendel Scott | Award | 3,456 | $4.34 | $14,999.04 | filing |
| 2026-06-30 | Miller Michael Francis· Chief Technology Officer | Tax withholding | 39 | $4.32 | $168.48 | filing |
| 2026-06-30 | Miller Michael Francis· Chief Technology Officer | Option exercise | 130 | — | — | filing |
| 2026-06-15 | Sriram Vandana· Chief Financial Officer | Tax withholding | 315 | $3.10 | $976.50 | filing |
| 2026-06-15 | Miller Michael Francis· Chief Technology Officer | Tax withholding | 249 | $3.10 | $771.90 | filing |
| 2026-06-15 | Sriram Vandana· Chief Financial Officer | Tax withholding | 154 | $3.10 | $477.40 | filing |
| 2026-06-15 | Miller Michael Francis· Chief Technology Officer | Tax withholding | 111 | $3.10 | $344.10 | filing |
| 2026-06-15 | Sriram Vandana· Chief Financial Officer | Tax withholding | 79 | $3.10 | $244.90 | filing |
| 2026-06-15 | Miller Michael Francis· Chief Technology Officer | Tax withholding | 41 | $3.10 | $127.10 | filing |
| 2026-06-15 | Miller Michael Francis· Chief Technology Officer | Tax withholding | 41 | $3.10 | $127.10 | filing |
| 2026-06-15 | Miller Michael Francis· Chief Technology Officer | Tax withholding | 25 | $3.10 | $77.50 | filing |
| 2026-06-15 | Miller Michael Francis· Chief Technology Officer | Option exercise | 834 | — | — | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.